tiprankstipranks
Trending News
More News >
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market

RaQualia Pharma Inc. (4579) Income Statement

Compare
1 Followers

RaQualia Pharma Inc. Income Statement

Last quarter (Q4 2024), RaQualia Pharma Inc.'s total revenue was ¥738.14M, an increase of 81.94% from the same quarter last year. In Q4, RaQualia Pharma Inc.'s net income was ¥-155.14M. See RaQualia Pharma Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 3.11B¥ 1.90B¥ 2.92B¥ 2.78B¥ 1.11B
Gross Profit
¥ 2.48B¥ 1.66B¥ 2.69B¥ 2.46B¥ 969.29M
Operating Expenses
¥ 2.70B¥ 1.99B¥ 1.82B¥ 1.75B¥ 1.46B
Depreciation and Amortization
¥ 401.65M¥ 175.56M¥ 147.73M¥ 141.56M¥ 124.25M
EBITDA
¥ 188.27M¥ -111.80M¥ 1.00B¥ 1.02B¥ -403.25M
Operating Income
¥ -213.38M¥ -337.37M¥ 866.24M¥ 707.86M¥ -486.08M
Other Income/Expenses
¥ -144.35M¥ 43.32M¥ -15.22M¥ 172.72M¥ -41.86M
Pretax Income
¥ -357.73M¥ -294.05M¥ 851.01M¥ 880.58M¥ -527.94M
Net Income
¥ -495.03M¥ -323.66M¥ 723.39M¥ 755.79M¥ -606.99M
Per Share Metrics
Basic EPS
¥ -22.87¥ -14.98¥ 34.50¥ 36.07¥ -28.97
Diluted EPS
¥ -22.87¥ -14.98¥ 34.47¥ 36.04¥ -28.97
Weighted Average Shares Outstanding
21.64M 21.61M 20.97M 20.95M 20.95M
Weighted Average Shares Outstanding (Diluted)
21.64M 21.61M 20.98M 20.97M 20.95M
Currency in JPY

RaQualia Pharma Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis